Some improve quickly with dietary changes
It also costs significantly more than alternatives that cover the basics just fine
A patient who feels tense, irritable, or flat on one stimulant class may do much better on the other, even when the diagnosis is clear and the dose is reasonable
In the United States alone, the number of patients starting GLP-1 treatments for non-diabetic purposes has increased by 700% since 2019, with estimates suggesting that over 220,000 patients started treatment each month in 2024
For now, it serves as a reminder of the importance of innovation in medicine
An enzymatically stable GIP/xenin hybrid peptide restores GIP sensitivity, enhances beta cell function and improves glucose homeostasis in high-fat-fed mice